PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall...

Area of Science:

• Biochemistry
• Molecular Biology
• Metabolic Research

Background:

• Insulin signaling is crucial for glucose and lipid metabolism.
• Phosphoinositide 3-kinase (PI3K) plays a key role in insulin action.
• The role of Protein Kinase C lambda (PKClambda) in hepatic insulin signaling and lipid metabolism requires further elucidation.

Purpose of the Study:

• To investigate the specific role of hepatic PKClambda in regulating insulin sensitivity and lipid homeostasis.
• To determine the molecular mechanisms by which PKClambda influences hepatic gene expression related to lipid synthesis.

Main Methods:

• Generation of liver-specific PKClambda knockout (L-lambdaKO) mice using the Cre-loxP system.
• Analysis of insulin sensitivity, hepatic triglyceride content, and gene expression (SREBP-1c) in L-lambdaKO mice.
• In vitro studies using primary rat hepatocytes to assess PKClambda's effect on SREBP-1c expression induced by insulin or PI3K.
• Adenovirus-mediated gene transfer to restore PKClambda expression in L-lambdaKO mice.

Main Results:

• L-lambdaKO mice exhibited enhanced insulin sensitivity and reduced hepatic triglyceride levels.
• Hepatic expression of SREBP-1c and its lipogenic target genes was significantly decreased in L-lambdaKO mice.
• Insulin- or PI3K-induced SREBP-1c expression in hepatocytes was inhibited by dominant-negative PKClambda and mimicked by WT PKClambda overexpression.
• Restoration of hepatic PKClambda normalized the metabolic abnormalities in L-lambdaKO mice.

Conclusions:

• Hepatic PKClambda is a critical determinant of hepatic lipid content.
• PKClambda plays a significant role in regulating whole-body insulin sensitivity.
• Targeting hepatic PKClambda may offer therapeutic strategies for metabolic disorders associated with insulin resistance and dyslipidemia.